Abstract
A recent study suggests that immunosuppression mediated by IDO, an enzyme that catabolizes tryptophan, may prevent rejection of the fetus by the maternal immune system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Medawar, P.B. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp. for the Soc. Exp. Biol. 7, 320 (1954).
Munn, D.H. et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191–1193 (1998).
Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991–1045 ( 1994).
Acknowledgements
We heartily thank Dr. Melvyn Heyes for educating us about IDO and tryptophan.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonney, E., Matzinger, P. Much IDO about pregnancy. Nat Med 4, 1128–1129 (1998). https://doi.org/10.1038/2624
Issue Date:
DOI: https://doi.org/10.1038/2624
This article is cited by
-
Tumors hijack fetal enzyme, escape killer T cells
Nature Medicine (2003)
-
Alternative activation of macrophages
Nature Reviews Immunology (2003)
-
T cell apoptosis by tryptophan catabolism
Cell Death & Differentiation (2002)